About Hindustan Bio Sciences Limited
Data last updated: 03 January 2026
Hindustan Bio Sciences Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 16 December 1991, the company has been in operation for over 35 years.
Registered with ROC Hyderabad under CIN L26942TG1991PLC013564. Listed on BSE: 532041.
Capital: an authorised share capital of ₹11 Cr and a paid-up capital of ₹2.05 Cr. It is led by directors including Prateek Reddy Gorrela and Ramachandra Raju Kalidindi.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.31Sagar Society Road No.2 Banjarahills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹81.32 Lakh, a decline of 23% compared to the previous year.
The company is associated with 1 brand - Hindustan Bio Sciences Limited. As per MCA filings, the company has open charges of ₹7.5 Cr and satisfied charges of ₹14.7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hindustanbiosciences.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressPlot No.31Sagar Society Road No.2 Banjarahills, Hyderabad, Telangana, India – 500034
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L26942TG1991PLC013564, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L26942TG1991PLC013564 | Current |
| U26942AP1991PLC013564 | Previous |
| L26942AP1991PLC013564 | Previous |
Associated Brands with Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited operates one associated brand: Hindustan Bio Sciences Limited. These brands represent Hindustan Bio Sciences Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Hindustan Bio Sciences Limited is engaged in pharmaceutical and biotechnology operations. | hindustanbiosciences.in |
Competitors & Alternatives of Hindustan Bio Sciences Limited
Brands and companies operating in the same space as Hindustan Bio Sciences Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Jubilant Life Sciences
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
Akums
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
Nectar Lifesciences
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
Windlas
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
Unither
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
Recipharm
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
CoreRx
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
MedPharm
|
Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom, United Kingdom | 1998 |
Business Activity of Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited is audited by VASG & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-04-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| VASG & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-04-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited is currently managed by 11 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Prateek Reddy Gorrela
Also directs:
Hindustan Bio Sciences Limited, Trans East Infra Llp, Misty Fall Valley Private Limited and 1 more
|
Director | 30 Sep 2024 | 1 Years 9 Months | Current |
|
Ramachandra Raju Kalidindi
Also directs:
Hindustan Bio Sciences Limited
|
Director | 30 Sep 2009 | 16 Years 9 Months | Current |
|
Bodeddula Nagireddy
Also directs:
Hindustan Bio Sciences Limited, Sendcrux Labs Private Limited
|
Director | 30 Sep 2024 | 1 Years 9 Months | Current |
| Uma Jampana | Director | 30 Oct 2007 | 18 Years 8 Months | Current |
| Reji Abraham | Director | 31 Oct 2023 | 2 Years 8 Months | Current |
|
Venkata Rama Mohan Raju Jampana
Also directs:
Hindustan Bio Sciences Limited, Basix Infratech India Private Limited, Nipuna Shelters Private Limited and 1 more
|
Managing Director | 10 Jun 2000 | 26 Years 0 Months | Current |
Financials of Hindustan Bio Sciences Limited FY 2026 filings available
Hindustan Bio Sciences Limited reported revenue of ₹73.71 Lakh (down 9.37% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹73.71 Lakh | ₹81.33 Lakh | ₹1.03 Cr | ₹92.23 Lakh | ₹43.65 Lakh | ₹1.03 Cr | ₹1.94 Cr | ₹3.56 Cr |
| Other Income | ₹0 | ₹0 | ₹2.4 Lakh | ₹0 | ₹5.24 Lakh | ₹0 | ₹0 | ₹6,000 |
| Total Income | ₹73.71 Lakh | ₹81.33 Lakh | ₹1.05 Cr | ₹92.23 Lakh | ₹48.89 Lakh | ₹1.03 Cr | ₹1.94 Cr | ₹3.56 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹44.9 Lakh | ₹49.39 Lakh | ₹64.25 Lakh | ₹57.03 Lakh | ₹28.93 Lakh | ₹34.03 Lakh | ₹1.53 Cr | ₹2.92 Cr |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹34.01 Lakh | -₹22.63 Lakh | -₹3.45 Lakh |
| Employee Benefit Expense | ₹19.35 Lakh | ₹12.58 Lakh | ₹14.56 Lakh | ₹23.92 Lakh | ₹24.05 Lakh | ₹24.64 Lakh | ₹25.73 Lakh | ₹22.41 Lakh |
| Finance Costs | ₹11,000 | ₹14,000 | ₹37,000 | ₹41,000 | ₹50,000 | ₹69,000 | ₹82,000 | ₹1.04 Lakh |
| Depreciation & Amortisation | ₹1.99 Lakh | ₹2,000 | ₹68,000 | ₹56,500 | ₹34,000 | ₹80,000 | ₹1.14 Lakh | ₹1.07 Lakh |
| Other Expenses | ₹15.29 Lakh | ₹9.38 Lakh | ₹20.08 Lakh | ₹14.1 Lakh | ₹46.52 Lakh | ₹1.05 Cr | ₹24.93 Lakh | ₹31.97 Lakh |
| Total Expenses | ₹81.64 Lakh | ₹71.51 Lakh | ₹99.94 Lakh | ₹96.03 Lakh | ₹1 Cr | ₹1.99 Cr | ₹1.83 Cr | ₹3.45 Cr |
| Profit Before Exceptional Items & Tax | -₹7.93 Lakh | ₹9.82 Lakh | ₹5.34 Lakh | -₹3.8 Lakh | -₹51.45 Lakh | -₹95.53 Lakh | ₹11.65 Lakh | ₹11.23 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹7.93 Lakh | ₹9.82 Lakh | ₹5.34 Lakh | -₹3.8 Lakh | -₹51.45 Lakh | -₹95.53 Lakh | ₹11.65 Lakh | ₹11.23 Lakh |
| Total Tax Expense | -₹3,000 | -₹26,000 | -₹43,000 | ₹25,000 | ₹31,000 | -₹1.55 Lakh | ₹3.56 Lakh | ₹23,000 |
| Net Profit | -₹7.9 Lakh | ₹10.08 Lakh | ₹5.77 Lakh | -₹4.05 Lakh | -₹51.76 Lakh | -₹93.98 Lakh | ₹8.09 Lakh | ₹11 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹7.9 Lakh | ₹10.08 Lakh | ₹5.77 Lakh | -₹4.05 Lakh | -₹51.76 Lakh | -₹93.98 Lakh | ₹8.09 Lakh | ₹11 Lakh |
| EBITDA (computed) | -₹5.83 Lakh | ₹9.98 Lakh | ₹6.39 Lakh | -₹2.82 Lakh | -₹50.61 Lakh | -₹94.04 Lakh | ₹13.61 Lakh | ₹13.34 Lakh |
| Basic EPS | ₹-0.08 | ₹0.10 | ₹0.06 | ₹-0.04 | ₹-0.50 | ₹-0.92 | ₹0.08 | ₹0.11 |
| Diluted EPS | ₹-0.08 | ₹0.10 | ₹0.00 | ₹0.00 | ₹-0.50 | ₹-0.92 | ₹0.08 | ₹0.11 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3.2 Cr | ₹3.42 Cr | ₹3.37 Cr | ₹3.29 Cr | ₹2.98 Cr | ₹3.49 Cr | ₹5.56 Cr | ₹5.63 Cr |
| Non-current Assets | ₹2.42 Cr | ₹2.43 Cr | ₹2.42 Cr | ₹2.43 Cr | ₹2.44 Cr | ₹2.59 Cr | ₹3.6 Cr | ₹3.63 Cr |
| Current Assets | ₹77.21 Lakh | ₹99.7 Lakh | ₹95 Lakh | ₹85.97 Lakh | ₹54.07 Lakh | ₹89.73 Lakh | ₹1.96 Cr | ₹2 Cr |
| Property, Plant & Equipment | ₹1.34 Lakh | ₹2.71 Lakh | ₹2.73 Lakh | ₹3.41 Lakh | ₹3.98 Lakh | ₹3.97 Lakh | ₹4.77 Lakh | ₹5.91 Lakh |
| Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹34.01 Lakh | ₹11.38 Lakh |
| Trade Receivables | ₹5.31 Lakh | ₹44.2 Lakh | ₹44.21 Lakh | ₹45.36 Lakh | ₹13.5 Lakh | ₹81.3 Lakh | ₹1.36 Cr | ₹1.67 Cr |
| Cash & Equivalents | ₹13.03 Lakh | ₹13,000 | ₹11,000 | ₹36,000 | ₹41,000 | ₹1.2 Lakh | ₹84,000 | ₹57,000 |
| Equity (Net Worth) | ₹82.6 Lakh | ₹90.5 Lakh | ₹80.42 Lakh | ₹74.66 Lakh | ₹78.71 Lakh | ₹1.3 Cr | ₹2.24 Cr | ₹2.16 Cr |
| Equity Share Capital | ₹2.05 Cr | ₹2.05 Cr | ₹2.05 Cr | ₹2.05 Cr | ₹10.25 Cr | ₹10.25 Cr | ₹10.25 Cr | ₹10.25 Cr |
| Borrowings (Non-current) | ₹2.35 Cr | ₹2.51 Cr | ₹2.56 Cr | ₹1.12 Cr | ₹1.07 Cr | ₹73.3 Lakh | ₹1.67 Cr | ₹2.26 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹1.33 Cr | ₹1.09 Cr | ₹1.13 Cr | ₹93.1 Lakh | ₹1.1 Cr |
| Total Debt (computed) | ₹2.35 Cr | ₹2.51 Cr | ₹2.56 Cr | ₹2.46 Cr | ₹2.17 Cr | ₹1.86 Cr | ₹2.6 Cr | ₹3.37 Cr |
| Current Liabilities | ₹1.99 Lakh | ₹1.36 Lakh | ₹1.38 Lakh | ₹1.42 Cr | ₹1.12 Cr | ₹1.45 Cr | ₹1.65 Cr | ₹1.2 Cr |
| Total Liabilities | ₹2.37 Cr | ₹2.52 Cr | ₹2.57 Cr | ₹2.54 Cr | ₹2.19 Cr | ₹2.18 Cr | ₹3.31 Cr | ₹3.47 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹28.13 Lakh | ₹2.71 Lakh | -₹7.54 Lakh | -₹28.85 Lakh | -₹31.21 Lakh |
| Investing Cash Flow | -₹63,000 | ₹0 | ₹0 | ₹0 | -₹35,000 |
| Financing Cash Flow | -₹15.56 Lakh | -₹5.12 Lakh | ₹10.1 Lakh | ₹28.89 Lakh | ₹30.8 Lakh |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹0 | ₹35,000 |
| Free Cash Flow (computed) | ₹28.13 Lakh | ₹2.71 Lakh | -₹7.54 Lakh | -₹28.85 Lakh | -₹31.56 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹11.94 Lakh | -₹2.41 Lakh | ₹2.56 Lakh | ₹3,700 | -₹76,000 |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹0 | ₹38.25 Lakh | ₹0 | ₹32.19 Lakh | ₹37.53 Lakh | ₹0 | ₹0 | ₹41.11 Lakh |
| Other Income | ₹2,000 | ₹1.78 Lakh | ₹86,000 | ₹1.31 Lakh | ₹1.26 Lakh | ₹0 | ₹0 | ₹1.43 Lakh |
| Total Income | ₹2,000 | ₹40.03 Lakh | ₹86,000 | ₹33.5 Lakh | ₹38.79 Lakh | ₹0 | ₹0 | ₹42.54 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹23.71 Lakh | ₹0 | ₹21.19 Lakh | ₹23.68 Lakh | ₹0 | ₹0 | ₹25.71 Lakh |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹4.96 Lakh | ₹4.97 Lakh | ₹4.96 Lakh | ₹4.4 Lakh | ₹3.31 Lakh | ₹3.26 Lakh | ₹3.01 Lakh | ₹3.01 Lakh |
| Finance Costs | ₹0 | ₹5,000 | ₹1,000 | ₹5,000 | ₹5,000 | ₹1,000 | ₹5,000 | ₹3,000 |
| Depreciation & Amortisation | ₹42,000 | ₹1.19 Lakh | ₹39,000 | ₹0 | -₹7,000 | ₹3,000 | ₹3,000 | ₹3,000 |
| Other Expenses | ₹6.3 Lakh | ₹1.92 Lakh | ₹1.35 Lakh | ₹6.47 Lakh | ₹1.02 Lakh | ₹84,000 | ₹1.93 Lakh | ₹5.58 Lakh |
| Total Expenses | ₹11.68 Lakh | ₹31.84 Lakh | ₹6.71 Lakh | ₹32.11 Lakh | ₹27.99 Lakh | ₹4.14 Lakh | ₹5.02 Lakh | ₹34.36 Lakh |
| Profit Before Exceptional Items & Tax | -₹11.66 Lakh | ₹8.19 Lakh | -₹5.85 Lakh | ₹1.39 Lakh | ₹10.8 Lakh | -₹4.14 Lakh | -₹5.02 Lakh | ₹8.18 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹11.66 Lakh | ₹8.19 Lakh | -₹5.85 Lakh | ₹1.39 Lakh | ₹10.8 Lakh | -₹4.14 Lakh | -₹5.02 Lakh | ₹8.18 Lakh |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹11.66 Lakh | ₹8.19 Lakh | -₹5.85 Lakh | ₹1.39 Lakh | ₹10.8 Lakh | -₹4.14 Lakh | -₹5.02 Lakh | ₹8.18 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹11.66 Lakh | ₹8.19 Lakh | -₹5.85 Lakh | ₹1.39 Lakh | ₹10.8 Lakh | -₹4.14 Lakh | -₹5.02 Lakh | ₹8.18 Lakh |
| EBITDA (computed) | -₹11.24 Lakh | ₹9.43 Lakh | -₹5.45 Lakh | ₹1.44 Lakh | ₹10.78 Lakh | -₹4.1 Lakh | -₹4.94 Lakh | ₹8.24 Lakh |
| Basic EPS | ₹-0.11 | ₹0.08 | ₹-0.06 | ₹0.01 | ₹0.11 | ₹-0.40 | ₹-0.05 | ₹0.08 |
| Diluted EPS | ₹-0.11 | ₹0.08 | ₹-0.06 | ₹0.01 | ₹0.11 | ₹-0.04 | ₹-0.05 | ₹0.08 |
Shareholding Pattern of Hindustan Bio Sciences Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 12.19%, retail and other public shareholders hold 87.81% of Hindustan Bio Sciences Limited. The company had 11,530 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 12.19% | 12.19% | 12.19% | 12.19% | 12.19% | 12.19% |
| Public | 87.81% | 87.81% | 87.81% | 87.81% | 87.81% | 87.81% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 12.19% | 12.19% | 12.19% |
| Public | 87.81% | 87.81% | 87.81% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Charges & Borrowings of Hindustan Bio Sciences Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 1994 | Andhra Pradesh State Financial Corporation | ₹14.7 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Hindustan Bio Sciences Limited
View historical data on people associated with Hindustan Bio Sciences Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Hindustan Bio Sciences Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Hindustan Bio Sciences Limited
GSTIN & GST Filing Data of Hindustan Bio Sciences Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Hindustan Bio Sciences Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Hindustan Bio Sciences Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Hindustan Bio Sciences Limited
MSME Payment Delays by Hindustan Bio Sciences Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Hindustan Bio Sciences Limited
Subsidiaries & Group Companies of Hindustan Bio Sciences Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Hindustan Bio Sciences Limited with ownership details.
MCA Filings & Documents of Hindustan Bio Sciences Limited
MCA Filings & Documents of Hindustan Bio Sciences Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Hindustan Bio Sciences Limited
Frequently Asked Questions about Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 16 December 1991 (35+ years old) and is registered under CIN L26942TG1991PLC013564. Listed on BSE: 532041.
Hindustan Bio Sciences Limited reported revenue of ₹81.32 Lakh for FY 2025 (down 23.00% YoY).
The current directors of Hindustan Bio Sciences Limited are:
- Prateek Reddy Gorrela
- Ramachandra Raju Kalidindi
- Bodeddula Nagireddy
- Jaison George
- Uma Jampana
- Jyothsna Sukavasi
- Reji Abraham
- Venkata Rama Mohan Raju Jampana
- Jaison George
- Devanshu Dange
- Shailendra Vyas
The primary industry of Hindustan Bio Sciences Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Hindustan Bio Sciences Limited is listed on BSE with code 532041.
Hindustan Bio Sciences Limited can be reached at the registered office: Plot No.31Sagar Society Road No.2 Banjarahills, Hyderabad, Telangana, India – 500034, or through the website hindustanbiosciences.in.